Global ESR tubes market is estimated to be valued at US$ 122.7 million in 2023, and is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030).
Analysts’ Views on Global ESR Tubes Market:
Increasing incidence of inflammation and adoption of growth strategies by the key players is expected to drive the global ESR tubes market growth over the forecast period. For instance, on June 28, 2023, according to World Health Organization, 13 million people with rheumatoid arthritis experience severity levels (moderate or severe) and in 2020, about 18 million people worldwide were living with rheumatoid arthritis.
Figure 1. Global ESR Tubes Market Share (%), By Material Type, 2023
To learn more about this report, request a free sample copy
Global ESR Tubes Market– Drivers
Increasing prevalence of inflammation
Increasing prevalence of inflammation caused due to the blood infections is expected to drive the market growth over the forecast period. For instance, in September 2022, according to an article published by Nature Reviews Rheumatology, 1.3% of U.S. adults (3 million) was diagnosed with the rheumatoid arthritis in 2020, and this increased by 17.3% in 2021 in the U.S.
Useful in differentiating iron deficiency from anemia of chronic disease
Useful in differentiating iron deficiency from anemia of chronic disease that helps the doctors to determine iron deficiency, and this expected to drive the market growth over the forecast period. For instance, in July 2022, according to an article published by American Family Physician, ESR test is also used to determine and differentiate iron deficiency from anemia of chronic disease and the test is also helpful in diagnosing few conditions including temporal arteritis, polymyalgia rheumatic and rheumatoid arthritis.
Figure 2. Global ESR Tubes Market Share (%), By Region, 2023
To learn more about this report, request a free sample copy
Global ESR Tubes Market - Regional Analysis
Among region, North America is estimated to hold a dominant position in the global ESR tubes market over the forecast period, owing to increasing prevalence of blood infection that leads to the diseases such as arthritis, kidney diseases, and certain cancers due to which the hospitalization rates are also increased. For instance, on February 03, 2023, according to a study published by SingleCare Administrators, in the U.S, almost 23% of overweight adults and 31% of adults with obesity were diagnosed with arthritis in 2020, and more than 560,000 hospitalizations in the U.S. involved rheumatoid arthritis.
Global ESR Tubes Market– Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.
COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others faced problems regarding transportation of drugs from one place to another.
However, the COVID-19 pandemic had negative impact on the global ESR tubes market, owing to decrease and delay in diagnostics screening, by directly affecting the production and demand, by creating disruptions in distribution channels, and through its financial impact on companies and financial markets. For instance, in July 2022, according to the study published by Diagnostics Journal in April 2022, during the first lockdown in April 2020, the number of tests dropped by 75.5%, after which the number of cases dropped up to 36.1% in 2021. During the first 24 months of the pandemic, the total volume of tests lost was 49.9%. The percentage of inflammation increased by 17%, while the number of newly diagnosed inflammation in the outpatient clinic decreased by 45% from the baseline.
Global ESR Tubes Market- Segmentation
The global ESR tubes market report is segmented into material type, end user, and region.
Among Material type, the global ESR tubes Market is segmented into plastic and glass. Out of which, the glass segment is expected to dominate the market over the forecast period due to increased blood infections and better compatibility than plastic with easy determination of sedimentation rate.
Among End User, the global ESR tubes market is segmented into hospitals, specialty centers, and others. Out of which, the hospitals segment is expected to dominate the global ESR tubes market over the forecast period, owing to increasing hospitalization rates due to increased prevalence of arthritis.
Among Region, the global ESR tubes market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Out of which, the North America is expected to dominate the global ESR tubes market over the forecast period due to increasing prevalence of blood infection and partnership agreement between the market players.
Among all segmentation, the end user segment has the highest potential due to increasing prevalence of blood infections over the forecast period. For instance, in September 2021, according to an article published by Antimicrobial Resist Infect Control Journal, 2.5 million cases of blood infections were reported in 2020 in Europe, and the prevalence of these blood infections increased to 3.5 million in 2021.
ESR Tubes Market Report Coverage
|Market Size in 2023:
|US$ 122.7 Mn
|Historical Data for:
|2018 to 2021
|2023 to 2030
|Forecast Period 2023 to 2030 CAGR:
|2030 Value Projection:
|US$ 179.6 Mn
Greiner Bio-One International GmbH, DWK LIFE SCIENCES LLC, OCULUS, ELITech Group, Thomas Scientific, STRECK, Geisinger Health, SOL-Millennium, Henso Medical (Hangzhou) Co.,Ltd., BD (Becton, Dickinson and Company), Zhejiang Gongdong Medical Technology Co., Ltd., ESBE Scientific Industries Inc., Medline Industries, Inc., KARTELL SPA VIA DELLE INDUSTRIE, SANLI Medical & Health Service, DD Biolab S.L., VACUTEST KIMA S.r.l, and Laboratory Corporation of America Holdings.
|Restraints & Challenges:
Global ESR Tubes Market - Cross Sectional Analysis
Among material type, the glass segment held a dominant position in North America region over the forecast period owing to increasing prevalence of blood infection which leads to the diseases such as arthritis, kidney diseases and certain cancers due to which the hospitalization rates increased. For instance, on June 22, 2023, according to article published by Centers for Diseases Control and Prevention, an estimated 78.4 million adults aged 18 years and older (25.9% of the projected total adult population) will have doctor-diagnosed arthritis in U.S. by 2040.
Global ESR Tubes Market- Key Developments
In July 2022, Sysmex Corporation, a supplier of medical devices, announced the launch of new sample transportation system modules that can be connected to the XR-Series Automated Hematology Analyzer ESR Tubes (XR-Series), its flagship models in the hematology field. The three modules, which are equipped with the functions of sample sorting, sample archiving, and automated transportation of quality control and cleaning materials, will contribute to greater automation and efficiency in clinical testing operations.
In January 2020, Beckman Coulter, Inc., a global company that engages in clinical diagnostics, announced the launch of the DxH 560 AL, a tabletop ESR analyzer that reduces the time and resource constraints faced by small to mid-sized laboratories. Analyzer’s auto-loading functionality, closed tube aspiration and walkaway capabilities allows users to add up to 50 samples, provide safety against blood-borne pathogens, and spend less time on manual instrument tasks. DxH 560 AL uses ~30% less counter space than other analyzers in its class.
On May 16, 2023, Siemens Healthcare GmbH, a provider of healthcare solutions and services, introduced two high-volume hematology test systems named the Atellica Hema 570 Analyzer and the Atellica Hema 580 Analyzer. The Atellica HEMA 570 Analyzer measures 43 cell parameters and an additional 12 parameters are available on the Atellica HEMA 580 Analyzer including immature red blood cell indicators relevant to certain patient populations, and an optical-based platelet count that reduces analytical interferences found in other detection technologies.
In July 2022, Rhinostics, a developer of sample collection kits for tests designed to increase the efficiency, accuracy, and safety of laboratories, introduced automated sample collection tube technologies by launching a patent-pending ESR tubes collection device that focuses on small volume blood collection.
Global ESR Tubes Market- Key Trends
Advancements in technology have led to the development of more sophisticated and user-friendly automated ESR analyzers. These analyzers features advanced software, improved measurement algorithms, and enhanced data management capabilities. For instance, on May 26, 2023, CML Biotech, a India-based manufacturer of blood collection tubes, installed the world’s first integrated machine ‘HUSKY-ICHOR’, for manufacturing blood collection tubes. The integrated machine comprises of machine mold, hot runner, dowser, dehumidifier, chiller, temperature controller, and dryer. Normally these functions are carried out in different machines. The machine is manufactured by Canada-based Husky Technologies, a global company that engages in injection molds and molding machines.
Global ESR Tubes Market: Restraints
Advancements in alternative diagnostic technologies such as next-generation sequencing (NGS) and Polymerase Chain Reaction (PCR)
Factors such as advancements in alternative diagnostic technologies such as next-generation sequencing (NGS) and polymerase chain reaction (PCR) is expected to restrain the global ESR tubes market growth. For instance on April 03, 2023, according to an article published by Molecular Medicine Reports, ESR diagnostic techniques have low detection rates, long detection times, and limited automation that means that these do not meet the requirements for rapid diagnosis. Continuous developments in molecular detection technology, which has a higher sensitivity and specificity, shorter detection time and increased automation, and performs an important role in the early and rapid detection of infectious disease pathogens. Therefore, progress in molecular diagnostic technologies such as PCR, isothermal amplification, gene chips, and high-throughput sequencing for the detection of infectious disease pathogens is more accurate as compared to the ESR. So, to avoid this, the accuracy of the ESR test analyzers to be increased as it has to be employed for determination of infectious pathogens.
Global ESR Tubes Market- Key Players
Major players operating in the global ESR tubes market include Greiner Bio-One International GmbH, DWK LIFE SCIENCES LLC, OCULUS, ELITech Group, Thomas Scientific, STRECK, Geisinger Health, SOL-Millennium, Henso Medical (Hangzhou) Co., Ltd., BD (Becton, Dickinson and Company), Zhejiang Gongdong Medical Technology Co., Ltd., ESBE Scientific Industries Inc., Medline Industries, Inc., KARTELL SPA VIA DELLE INDUSTRIE, SANLI Medical & Health Service, DD Biolab S.L., VACUTEST KIMA S.r.l, and Laboratory Corporation of America Holdings.
*Definition: Erythrocyte sedimentation is a commonly used hematology test to measure inflammation and the presence and severity of disease. The erythrocyte sedimentation rate (ESR) is a nonspecific indicator of disease activity, and is often used by clinicians in assisting diagnosis and follow-up of many inflammatory disorders.
Frequently Asked Questions